CVS Health (CVS) said Friday that data from its weight management program showed participants lost an average of 15% of their weight.
The data was derived from 265,000 patients participating in the program. They included those using GLP-1 anti-obesity medications, who nearly doubled their pre-program weight loss while working with the program to change their diet and lifestyle, the company said.
"The data are clear: GLP-1 weight-loss drugs work best when combined with nutrition, lifestyle support and proper dosing2," said Michelle Gourdine, chief medical officer at CVS Caremark.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.